Traditional Medicinal Plants and Malaria

Traditional Medicinal Plants and Malaria (Traditional Herbal Medicines for Modern Times, V. 4)
by Merlin Willcox (Editor), Gerard Bodeker (Editor), Philippe Rasoanaivo (Editor), Jonathan Addae-Kyereme (Editor)

Product Details:
* Hardcover: 552 pages
* Publisher: CRC (June 15, 2004)
* Language: English
* ISBN-10: 0415301122

Book Description:
Malaria is an increasing worldwide threat, with more than three hundred million infections and one million deaths every year. The world's poorest are the worst affected, and many treat themselves with traditional herbal medicines. These are often more available and affordable, and sometimes are perceived as more effective than conventional antimalarial drugs. The first book to be published on this subject, Traditional Medicinal Plants and Malaria explores the evidence for the safety and efficacy of some of these traditional medicines, and presents practical guidelines for designing studies on traditional plant-based antimalarial medicines, mosquito repellents, and insecticides. Systematic reviews of the literature and consensus guidelines form the main body of the book. Ethnomedical, ethnobotanical, pharmacological, phytochemical, toxicological, and clinical aspects of herbal antimalarials are also reviewed. These are supplemented by case studies of the most well-known traditional antimalarials.

Download

Entry Inhibitors in HIV Therapy

Entry Inhibitors in HIV Therapy (Milestones in Drug Therapy)
by Jacqueline D. Reeves (Editor), Cynthia A. Derdeyn (Editor)

Product Details:
* Hardcover: 200 pages
* Publisher: Birkhäuser Basel; 1 edition (July 2007)
* Language: English
* ISBN-10: 3764377828

Book Description
Entry Inhibitors in HIV Therapy details the current status of this relatively new and very dynamic class of inhibitors, appealing to both the clinician and basic research scientist. A unique overview of obstacles and accomplishments is presented. The book features chapters that explain the challenges of high sequence diversity in the viral envelope gene for the development and use of entry inhibitors, the clinical utility of virus phenotyping, the development of this class of inhibitors as microbicidal therapy, and the success story of enfuvirtide from the bench to FDA approval. Both basic research findings and results of clinical studies are covered and linked together by a diverse panel of experts in the field.

Download